| Pulmonary impairment after tuberculosis and its contribution to TB burden JG Pasipanodya, SJN McNabb, P Hilsenrath, S Bae, K Lykens, E Vecino, ... BMC public health 10, 1-10, 2010 | 137 | 2010 |
| Percutaneous needle biopsy of musculoskeletal lesions. 2. Cost-effectiveness. MA Fraser-Hill, DL Renfrew, PE Hilsenrath AJR. American journal of roentgenology 158 (4), 813-818, 1992 | 136 | 1992 |
| Medical checkups: who does not get them? D Culica, J Rohrer, M Ward, P Hilsenrath, P Pomrehn American Journal of Public Health 92 (1), 88-91, 2002 | 119 | 2002 |
| Personal and societal health quality lost to tuberculosis TL Miller, SJN McNabb, P Hilsenrath, J Pasipanodya, SE Weis PloS one 4 (4), e5080, 2009 | 98 | 2009 |
| The World Health Report 2000: can health care systems be compared using a single measure of performance? JS Coyne, P Hilsenrath American Journal of Public Health 92 (1), 30-33, 2002 | 96 | 2002 |
| Gastric bypass surgery in the United States, 1998–2002 TM Smoot, P Xu, P Hilsenrath, NC Kuppersmith, KP Singh American Journal of Public Health 96 (7), 1187-1189, 2006 | 70 | 2006 |
| Gasoline prices and their relationship to rising motorcycle fatalities, 1990–2007 FA Wilson, JP Stimpson, PE Hilsenrath American journal of public health 99 (10), 1753-1758, 2009 | 57 | 2009 |
| Medical marijuana knowledge and attitudes: a survey of the California Pharmacists Association D Szyliowicz, P Hilsenrath Journal of primary care & community health 10, 2150132719831871, 2019 | 50 | 2019 |
| Analysis of the cost-effectiveness of PACS. PE Hilsenrath, WL Smith, KS Berbaum, EA Franken, DA Owen AJR. American journal of roentgenology 156 (1), 177-180, 1991 | 49 | 1991 |
| Price-transparency and cost accounting: challenges for health care organizations in the consumer-driven era P Hilsenrath, C Eakin, K Fischer INQUIRY: The Journal of Health Care Organization, Provision, and Financing …, 2015 | 42 | 2015 |
| Why rural residents migrate for family physician care TF Borders, JE Rohrer, PE Hilsenrath, MM Ward The Journal of rural health 16 (4), 337-348, 2000 | 42 | 2000 |
| Recombinant Human Erythropoietin vs Transfusions in the Treatment of Anemia of Prematurity: A Cost-benefit Analyis TI Shireman, PE Hilsenrath, RG Strauss, JA Widness, AH Mutnick Archives of pediatrics & adolescent medicine 148 (6), 582-588, 1994 | 41 | 1994 |
| A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity J Fain, P Hilsenrath, JA Widness, RG Strauss, AH Mutnick Transfusion 35 (11), 936-943, 1995 | 40 | 1995 |
| The societal cost of tuberculosis: Tarrant County, Texas, 2002 TL Miller, SJN McNabb, P Hilsenrath, J Pasipanodya, G Drewyer, ... Annals of epidemiology 20 (1), 1-7, 2010 | 38 | 2010 |
| Cost‐effectiveness of a limited‐donorblood program for neonatal red cell transfusions P Hilsenrath, J Nemechek, JA Widness, DG Cordle, RG Strauss Transfusion 39 (9), 938-943, 1999 | 38 | 1999 |
| Using cost and health impacts to prioritize the targeted testing of tuberculosis in the United States TL Miller, P Hilsenrath, K Lykens, SJN Mcnabb, PK Moonan, SE Weis Annals of epidemiology 16 (4), 305-312, 2006 | 34 | 2006 |
| Geographic variation in primary care visits in Iowa. LW Briggs, JE Rohrer, RL Ludke, PE Hilsenrath, KT Phillips Health services research 30 (5), 657, 1995 | 33 | 1995 |
| Healthcare management education settings in the United States: History and perspective PE Hilsenrath Journal of Management History 18 (4), 386-401, 2012 | 30 | 2012 |
| Health Policy as Counter‐Terrorism: Health Services and the Palestinians P Hilsenrath Defence and Peace Economics 16 (5), 365-374, 2005 | 26 | 2005 |
| Cost-effective osteopathic manipulative medicine: a literature review of cost-effectiveness analyses for osteopathic manipulative treatment R Gamber, S Holland, DP Russo, A Cruser, PE Hilsenrath Journal of Osteopathic Medicine 105 (8), 357-367, 2005 | 24 | 2005 |
